ScoreWhy is Titan Biotech Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.04 times
2
Poor long term growth as Operating profit has grown by an annual rate -6.32% of over the last 5 years
3
With a growth in Net Profit of 107.11%, the company declared Very Positive results in Dec 25
- The company has declared positive results for the last 2 consecutive quarters
- PBT LESS OI(Q) Highest at Rs 9.30 cr.
- NET SALES(Q) Highest at Rs 56.51 cr
- PBDIT(Q) Highest at Rs 10.84 cr.
4
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 22-May-26 and has generated 5% returns since then
- The stocks MACD and KST technical factors are also Bullish
5
With ROE of 13.9, it has a Very Expensive valuation with a 11.2 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 418.72%, its profits have risen by 20.9% ; the PEG ratio of the company is 3.3
6
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Titan Biotech should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Titan Biotech for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Titan Biotech
76.18%
4.02
104.05%
Sensex
-11.8%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.69%
EBIT Growth (5y)
-1.45%
EBIT to Interest (avg)
28.25
Debt to EBITDA (avg)
0.23
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
1.19
Tax Ratio
28.18%
Dividend Payout Ratio
7.68%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
23.53%
ROE (avg)
19.48%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
47
Industry P/E
42
Price to Book Value
8.82
EV to EBIT
43.15
EV to EBITDA
37.90
EV to Capital Employed
8.66
EV to Sales
7.34
PEG Ratio
0.88
Dividend Yield
0.13%
ROCE (Latest)
18.17%
ROE (Latest)
16.46%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend22What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 9.03 times
NET SALES(Q)
Highest at Rs 59.17 cr
PBDIT(Q)
Highest at Rs 12.49 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 21.11%
PBT LESS OI(Q)
Highest at Rs 10.92 cr.
PAT(Q)
Highest at Rs 10.86 cr.
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 1.87 cr
Loading Valuation Snapshot...
Here's what is working for Titan Biotech
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 10.92 cr has Grown at 47.77%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 10.86 cr has Grown at 58.3%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 59.17 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 59.17 cr has Grown at 27.25%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 12.49 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 21.11%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 10.92 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 10.86 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Debtors Turnover Ratio- Half Yearly
Highest at 9.03 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Titan Biotech
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 1.87 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
